BioSpace News Archive

Acorai, a start-up medical device manufacturer from Sweden, has announced closing an oversubscribed series seed equity round.

BPGbio, Inc today announced the appointment of Ritesh Srivastava as General Counsel.

Curasight A/S announced the achievement of the first milestone under the agreement with Curium inc., to develop Curasight’s uTRACE® PET imaging technology for the improved diagnosis of prostate cancer.

ProteinLogic announced that they have received a $1.35 million grant from the Bill & Melinda Gates Foundation to accelerate the development of ImmiPrint® Technology to monitor treatment responses to TB antimicrobial chemotherapy.

AC Immune to Regain Global Rights to Crenezumab and Semorinemab Company’s strategy is focused on advancing the Phase 2 development of its three active immunotherapies Active immunotherapy now considered to be the optimal approach for precision prevention of neurodegenerative diseases.

Neumora Therapeutics, Inc. today announced the appointment of Kaya Pai Panandiker as chief commercial officer and a member of Neumora’s executive team, reporting to Henry Gosebruch, president and chief executive officer.

Kraig Biocraft Laboratories, Inc., shares an update on near-term commercial applications and opportunities for recombinant spider silk as the Company prepares for expanding production in 2024.

Samsung Biologics, a global contract development and manufacturing organization, announced that the company was awarded the EcoVadis’ Platinum Sustainability Rating, the highest recognition given, for the company’s sustainability management.

Invitae (NYSE: NVTA), a leading medical genetics company, today announced it has completed the sale of certain reproductive health assets, which include carrier screening and non-invasive prenatal screening, to Natera (NASDAQ: NTRA).

AstraZeneca announces AIRSUPRA ® (albuterol/budesonide), is now commercially available in the US by prescription. AIRSUPRA received FDA approval in January 2023 for the as-needed treatment or prevention of symptoms of asthma and to help prevent sudden severe breathing problems (asthma attacks) in people aged 18 years and older.